FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.5056
+0.0152 (3.10%)
At close: Oct 8, 2025, 4:00 PM EDT
0.5049
-0.0007 (-0.14%)
Pre-market: Oct 9, 2025, 5:14 AM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $21.18 million as of October 8, 2025. Its market cap has decreased by -81.80% in one year.
Market Cap
21.18M
Enterprise Value
23.11M
1-Year Change
-81.80%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $21.18M, a decrease of -97.76%. That is a compound annual growth rate of -89.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 20.54M | -70.73% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.06B |
| Johnson & Johnson | 452.65B |
| AbbVie | 404.12B |
| UnitedHealth Group | 325.86B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.27B |